BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pedro-Botet J, Ascaso JF, Barrios V, De la Sierra A, Escalada J, Millán J, Mostaza JM, Pérez-Martínez P, Pintó X, Salas-Salvadó J, Valdivielso P. COSMIC project: consensus on the objectives of the metabolic syndrome in clinic. Diabetes Metab Syndr Obes 2018;11:683-97. [PMID: 30464566 DOI: 10.2147/DMSO.S165740] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Slouma M, Ben Ali K, Kharrat L, Zouaoui C, Ouertani H, Gharsallah I. Athrogenic indexes: Useful markers for predicting metabolic syndrome in axial spondyloarthritis. Clínica e Investigación en Arteriosclerosis (English Edition) 2022;34:261-268. [DOI: 10.1016/j.artere.2022.09.001] [Reference Citation Analysis]
2 Slouma M, Ben Ali K, Kharrat L, Zouaoui C, Ouertani H, Gharsallah I. Athrogenic indexes: Useful markers for predicting metabolic syndrome in axial spondyloarthritis. Clínica e Investigación en Arteriosclerosis 2022;34:261-268. [DOI: 10.1016/j.arteri.2022.03.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mostaza J, Pintó X, Armario P, Masana L, Real J, Valdivielso P, Arrobas-velilla T, Baeza-trinidad R, Calmarza P, Cebollada J, Civera-andrés M, Cuende Melero J, Díaz-díaz J, Fernández Pardo J, Guijarro C, Jericó C, Laclaustra M, Lahoz C, López-miranda J, Martínez-hervás S, Muñiz-grijalvo O, Páramo J, Pascual V, Pedro-botet J, Pérez-martínez P, Plana N, Puzo J, Sánchez Chaparro M, Vila L. SEA 2022 standards for the comprehensive control of cardiovascular risk. Clínica e Investigación en Arteriosclerosis (English Edition) 2022;34:130-179. [DOI: 10.1016/j.artere.2022.06.002] [Reference Citation Analysis]
4 Mostaza JM, Pintó X, Armario P, Masana L, Real JT, Valdivielso P, Arrobas-Velilla T, Baeza-Trinidad R, Calmarza P, Cebollada J, Civera-Andrés M, Cuende Melero JI, Díaz-Díaz JL, Fernández Pardo J, Guijarro C, Jericó C, Laclaustra M, Lahoz C, López-Miranda J, Martínez-Hervás S, Muñiz-Grijalvo O, Páramo JA, Pascual V, Pedro-Botet J, Pérez-Martínez P, Plana N, Puzo J, Sánchez Chaparro MÁ, Vila L. SEA 2022 Standards for Global Control of Cardiovascular Risk. Clin Investig Arterioscler 2022;34:130-79. [PMID: 35090775 DOI: 10.1016/j.arteri.2021.11.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Teixeira JE, Bragada JA, Bragada JP, Coelho JP, Pinto IG, Reis LP, Fernandes PO, Morais JE, Magalhães PM. Structural Equation Modelling for Predicting the Relative Contribution of Each Component in the Metabolic Syndrome Status Change. IJERPH 2022;19:3384. [DOI: 10.3390/ijerph19063384] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
6 Silva-Boghossian CM, Dezonne RS. What Are the Clinical and Systemic Results of Periodontitis Treatment in Obese Individuals? Curr Oral Health Rep 2021;:1-18. [PMID: 34367878 DOI: 10.1007/s40496-021-00295-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Núñez-cortés JM, Pedro-botet J. Atherogenic dyslipidaemia: the other pandemic, associated with diabesity. Clínica e Investigación en Arteriosclerosis (English Edition) 2021;33:30-32. [DOI: 10.1016/j.artere.2021.01.002] [Reference Citation Analysis]
8 Núñez-cortés JM, Pedro-botet J. Dislipemia aterogénica: la otra pandemia, asociada a la diabesidad. Clínica e Investigación en Arteriosclerosis 2021;33:30-32. [DOI: 10.1016/j.arteri.2020.12.001] [Reference Citation Analysis]
9 Pedro-botet J, Ascaso JF, Blasco M, Brea Á, Díaz Á, Hernández-mijares A, Pintó X, Millán J. Triglycerides, HDL cholesterol and atherogenic dyslipidaemia in the 2019 European guidelines for the management of dyslipidaemias. Clínica e Investigación en Arteriosclerosis (English Edition) 2020;32:209-218. [DOI: 10.1016/j.artere.2019.12.001] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
10 Cui F, Hu HF, Guo J, Sun J, Shi M. The Effect of Autophagy on Chronic Intermittent Hypobaric Hypoxia Ameliorating Liver Damage in Metabolic Syndrome Rats. Front Physiol 2020;11:13. [PMID: 32082187 DOI: 10.3389/fphys.2020.00013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]